The Brown/LUNGevity Award for Immunotherapy Resistance funds high-impact research to understand resistance to first-line immunotherapy and develop therapeutic strategies targeting this resistance. The program is open to both US and non-US applicants and has no geographical restrictions. All application materials must be submitted electronically via proposalCENTRAL